Beasley, TX

By Deena Beasley Nov 2 (Reuters) – The recent failure of a Novartis experimental heart drug in a large trial raised questions among cardiologists and investors about the widely held idea that reducing levels of a genetically set cholesterol carrier called lipoprotein(a) can improve heart… The post Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target appeared first on KSEV Radio 700.

By Deena Beasley Oct 29 (Reuters) – Bristol ​Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share projection due to a hefty acquisition-related charge. The US drugmaker said it now expects… The post Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge appeared first on KSEV Radio 700.

Veteran guard Malik Beasley will enter a guilty plea in his federal betting-related bribery and conspiracy case, Beasley's attorney, Steve Haney, told...

In this April 24, 2025, file photo, Malik Beasley #5 of the Detroit Pistons shoots the ball during the first half against the New York Knicks in Game Three of the Eastern Conference First Round NBA Playoffs at Little Caesars Arena in Detroit, Michigan. (Gregory Shamus/Getty Images, FILE) Former NBA player Malik Beasley intends to plead guilty to federal charges that accused him and five others of taking part in a bribery and betting scheme, according to a court notice filed overnight Saturday. B

Former NBA player Malik Beasley is negotiating a plea agreement with the Department of Justice after initially pleading not guilty to charges that he altered his play in certain games in 2024 to enrich sports bettors and ease his own debts, his attorney said Saturday. In July, Beasley entered a not guilty plea in New … Continue reading Former NBA star Malik Beasley negotiating plea deal over gambling charges

Malik Beasley's attorney says the former NBA guard is working on a plea deal in his federal betting and bribery case.Attorney Steve Haney told ESPN on...

By Deena Beasley Oct 24 (Reuters) – Amgen’s Imdelltra used in combination with AstraZeneca’s immunotherapy Imfinzi reduced the risk of death by 58% compared to the Astra drug alone in patients with extensive-stage small cell lung cancer, according to data from a study presented at… The post Amgen drug combined with immunotherapy extends survival in lung cancer trial appeared first on KSEV Radio.

By Deena Beasley Oct 7 (Reuters) – Novartis’ experimental del-desiran for a rare type of muscular dystrophy was expected to be a winner, with the Swiss company’s CEO predicting annual peak sales of $5 billion. When a late-stage trial missed its goal last month, shares…